Immediate Impact
1 by Nobel laureates 5 from Science/Nature 62 standout
Citing Papers
Past, present, and future of CRISPR genome editing technologies
2024 Standout
Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
Works of M.J. Requena being referenced
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M.J. Requena | 552 | 269 | 76 | 257 | 48 | 1.0k | |
| Malachi J. Flanagan | 818 | 334 | 26 | 272 | 29 | 1.4k | |
| Alastair Hansen | 235 | 302 | 29 | 218 | 51 | 1.3k | |
| Shiu-Feng Huang | 423 | 237 | 57 | 337 | 41 | 1.1k | |
| Kevin A. David | 310 | 223 | 93 | 650 | 41 | 1.2k | |
| Kara A. Lombardo | 392 | 265 | 12 | 373 | 59 | 941 | |
| S. Glüer | 626 | 376 | 51 | 138 | 68 | 1.2k | |
| Raffaella Santi | 313 | 196 | 59 | 242 | 88 | 1.2k | |
| Claus‐Dieter Gerharz | 414 | 601 | 30 | 451 | 61 | 1.3k | |
| E. Cohen | 200 | 195 | 22 | 185 | 42 | 1.1k | |
| Florence Joly | 360 | 236 | 53 | 463 | 53 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...